Phase I Trial of Intra-arterial Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Multiple System Atrophy

Table 1

Demographic and clinical characteristics of study participants.

Case ID	Age (yr)	Sex	Age of	Disease	UMSARS at screening (V1)
			Onset (yr)	Duration (mo)	Part I	Part II	Part IV	Total
Low-dose group
S-101	62	F	58	39.0	19	24	3	46
S-102	49	M	46	33.3	21	20	2	43
S-103	64	F	61	30.1	20	17	3	40
Medium-dose group
S-201	63	M	59	44.7	17	20	3	40
S-202	68	M	67	16.6	17	18	2	37
S-203	57	M	55	20.7	15	14	1	30
High-dose group
S-301	52	M	51	21.0	18	22	2	42
S-302	51	F	49	32.5	24	17	3	44
S-303	48	F	47	11.1	14	17	2	33

UMSARS: Unified Multiple System Atrophy Rating Scale.